Clinical trial
The Effects of Sacubitril/Valsartan Compared to Valsartan on Left Ventricular Remodelling in Asymptomatic Left Ventricular Systolic Dysfunction After Myocardial Infarction: a Randomised, Double-blinded, Active-comparator, Cardiac-MR Based Trial
NCT03552575 is registered in ClinicalTrials.gov with NHS Greater Glasgow and Clyde as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Sacubitril/Valsartan Compared to Valsartan on Left Ventricular Remodelling in Asymptomatic Left Ventricular Systolic Dysfunction After Myocardial Infarction: a Randomised, Double-blinded, Active-comparator, Cardiac-MR Based Trial
- Lead sponsor
- NHS Greater Glasgow and Clyde
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 1, 2018
- Completion date
- July 25, 2020
- Enrollment
- 93 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.